山东威高集团医用高分子制品股份有限公司（威高股份，股票代码：01066）于2026年4月24日公告，2026年4月24日在香港联交所场内回购股份12万股，约占该次交易前已发行股本的0.0027%。回购价格区间介乎每股3.60港元至3.71港元，合计耗资约44.08万港元。
根据公告显示，回购完成后，公司已发行股本变动为44.69586724亿股，库藏股数量增至5274.56万股。本次回购依据2025年5月27日通过的购回授权进行，该授权可购回股份总数为4.51560392亿股，截至目前公司已回购约4609.72万股。
公司同时确认已遵守香港联交所《上市规则》及相关法律法规，本次回购由公司董事会及相关决议正式批准，公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.